Blood Test Reveals Clues to Lymphoma Patients' Outcomes (IMAGE)

American Association for the Advancement of Science (AAAS)

Blood Test Reveals Clues to Lymphoma Patients' Outcomes

Caption

Framework for noninvasive identification of diffuse large B cell lymphoma (DLBCL) poor-risk groups at different disease milestones is shown. This material relates to a paper that appeared in the Nov. 9, 2016, issue of Science Translational Medicine, published by AAAS. The paper, by F. Scherer at Stanford University, Department of Medicine in Stanford, CA, and colleagues was titled, "Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA."

Credit

F. Scherer <i>et al., Science Translational Medicine</i> (2016)

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.